Imagine if your car insurance only covered the engine but not the wheels; that is how dental care often works. This work creates a better way to decide which treatments are essential and how to pay for them so people don't go broke getting a tooth fixed. It is like building a smarter pricing and coverage guide for the entire dental industry.
Oral health care in the EU is inefficiently funded, leading to high costs and limited patient access. This creates a gap where preventable diseases become expensive emergencies due to poor payment and insurance structures.
A set of oral health system indicators, a monitoring system, and the PRUDENT Financing Companion containing policy briefs and digital decision aid tools.
If you are an insurer dealing with unpredictable dental claim costs — this project developed a set of system indicators and financing mechanisms that help stabilize resource planning and coverage limits.
If you are a software firm dealing with a lack of clinical decision tools — this project developed digital decision aid tools that guide providers on resource use and prioritization.
If you are a government body dealing with the fact that oral diseases are the 3rd most expensive to treat — this project developed a monitoring system to track performance and reduce waste.
The project aims to reduce financial hardship for citizens and waste at the macro level by optimizing how oral care is financed. Based on available project data, it targets the fact that oral diseases are the 3rd most expensive to treat in the EU.
The project is designed for EU-wide application, implementing a monitoring system across 11 countries. Based on available project data, the goal is a step change in collective problem solving for the entire EU population.
Based on available project data, there is no specific mention of patents or licensing terms, though innovation management is listed as a task in progress.
The project focuses on oral health financing mechanisms and regulatory learning to bridge the gap between research and policy. It aligns with the 2021 WHO Oral Health Resolution.
The project period runs from 2023-01-01 to 2027-12-31, indicating a multi-year development and testing phase.
The consortium is heavily academic, consisting of 9 universities and 2 research organizations out of 13 total partners. There is a notable absence of large industry players (0% industry ratio), though 2 SMEs are involved. This suggests the output will be highly evidence-based and theoretical, requiring a strong bridge to commercialize the resulting decision tools.
Contact Stichting Radboud Universitair Medisch Centrum in the Netherlands
Contact us to identify potential licensing opportunities for the PRUDENT Financing Companion tools.
